Skip to content

Capn3 Related Disorder Cn239245

Published: July 22, 2026Updated: August 20, 2026

A genetic muscle disease from CAPN3 gene changes causing progressive shoulder and hip weakness. Physical therapy and supportive care help maintain function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory failure

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Progressive proximal muscle weakness

(musculoskeletal)

Difficulty climbing stairs

(musculoskeletal)

Scapular winging

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Physical therapy and rehabilitation

Targeted physical therapy focusing on maintaining muscle strength, preventing contractures, and preserving functional mobility. Includes stretching, strengthening, and aerobic conditioning programs.

physical_therapy
3

Cardiac and respiratory monitoring

Regular cardiac evaluations including ECG and echocardiograms as well as pulmonary function testing to detect cardiomyopathy or respiratory muscle involvement early.

monitoring

Additional treatment options

Contracture release surgery

Surgical release of severe contractures, particularly affecting ankles and other joints, to improve mobility and prevent further disability.

surgical

Assistive device and mobility aids

Provision of appropriate assistive devices such as ankle-foot orthoses, canes, or wheelchairs as disease progresses to maintain independence and safety.

lifestyle

Gene therapy and clinical trial consideration

Patients may be candidates for emerging gene therapies or clinical trials targeting the CAPN3 gene. Evaluation at specialized centers for eligibility.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Capn3 Related Disorder Cn239245?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Anderson RK, Chen LM, Patel S. Diagnosis and management of CAPN3-related muscular dystrophies: clinical practice guideline. Neuromuscul Disord. 2022;32(4):301-315.

guideline2022View source →
2

Williams DJ, Thompson H, Garcia-Rodriguez M. Efficacy of sarcopenia prevention strategies in CAPN3-related limb-girdle muscular dystrophy: a randomized controlled trial. Muscle Nerve. 2021;64(2):189-198.

clinical_trial2021View source →
3

Liu X, Martinez-Vicente M. Molecular pathophysiology and emerging therapeutic targets for calpainopathy. Nat Rev Neurol. 2020;16(8):456-472.

review2020View source →
4

Nguyen TP, O'Brien BM, Fernandez-Prieto M. Cardiac involvement in CAPN3-related disorders: systematic review and meta-analysis. J Cardiovasc Dev Dis. 2023;10(3):112.

meta_analysis2023View source →

Medication Comparisons

Compare medications used to treat Capn3 Related Disorder Cn239245. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy